-
Revenue
-
Net Income
-
Gross Margin
-
Op. Margin
-
Free Cash Flow
| Breakdown | TTM (Sep 30, 2025) |
FY 2024 (Mar 31, 2025) |
FY 2023 (Mar 31, 2024) |
FY 2022 (Mar 31, 2023) |
FY 2021 (Mar 31, 2022) |
FY 2020 (Mar 31, 2021) |
FY 2019 (Mar 31, 2020) |
|---|---|---|---|---|---|---|---|
| Total Revenue | - | $1.70B | $1.43B | $1.16B | $929.45M | $703.51M | $545.80M |
| Revenue Growth % | nan% | 18.7% | 23.5% | 24.6% | 32.1% | 28.9% | nan% |
| Cost of Revenue | - | $320.19M | $266.45M | $222.89M | $172.88M | $127.71M | $128.93M |
| Gross Profit | - | $1.38B | $1.16B | $935.64M | $756.57M | $575.80M | $416.87M |
| Gross Margin % | nan% | 81.2% | 81.4% | 80.8% | 81.4% | 81.8% | 76.4% |
| Operating Expenses | - | $1.20B | $1.04B | $842.83M | $675.26M | $483.90M | $588.81M |
| Research & Development | - | $384.57M | $304.74M | $218.35M | $156.34M | $111.42M | $119.28M |
| Operating Income | - | $179.43M | $128.40M | $92.81M | $81.31M | $91.90M | $-171.94M |
| Operating Margin % | nan% | 10.6% | 9.0% | 8.0% | 8.7% | 13.1% | -31.5% |
| Interest Expense | - | $753.00K | $851.00K | $3.41M | $10.19M | $14.21M | $45.40M |
| Other Income/Expense | - | $-4.29M | $-10.77M | $565.00K | $544.00K | $162.00K | $-1.20M |
| Income Before Tax | - | $223.43M | $154.91M | $89.97M | $71.66M | $77.85M | $-218.53M |
| Income Tax Expense | - | $-260.25M | $283.00K | $-17.99M | $19.21M | $2.14M | $199.49M |
| Net Income | - | $483.68M | $154.63M | $107.96M | $52.45M | $75.71M | $-418.02M |
| Net Margin % | nan% | 28.5% | 10.8% | 9.3% | 5.6% | 10.8% | -76.6% |
| Basic EPS | nan | 1.62 | 0.53 | 0.38 | 0.18 | 0.27 | -1.56 |
| Diluted EPS | nan | 1.59 | 0.52 | 0.37 | 0.18 | 0.26 | -1.56 |
| Basic Shares Outstanding | 301.6M | 298.4M | 294.1M | 287.7M | 284.2M | 280.5M | 264.9M |
| Diluted Shares Outstanding | 304.3M | 303.6M | 299.3M | 291.6M | 290.9M | 286.5M | 264.9M |
| Breakdown | FY 2024 (Mar 31, 2025) |
FY 2023 (Mar 31, 2024) |
FY 2022 (Mar 31, 2023) |
FY 2021 (Mar 31, 2022) |
FY 2020 (Mar 31, 2021) |
FY 2019 (Mar 31, 2020) |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.02B | $778.98M | $555.35M | $462.97M | $324.96M | $213.17M |
| Short-term Investments | $96.19M | $57.89M | - | - | - | - |
| Accounts Receivable | $624.44M | $602.74M | $442.52M | $350.67M | $242.08M | $157.06M |
| Other Current Assets | $83.90M | $66.75M | $37.29M | $72.19M | $64.25M | $61.19M |
| Total Current Assets | $1.93B | $1.61B | $1.12B | $948.42M | $680.28M | $469.93M |
| Property Plant & Equipment | $61.52M | $53.33M | $53.58M | $45.27M | $36.92M | $31.51M |
| Goodwill | $1.34B | $1.34B | $1.28B | $1.28B | $1.27B | $1.27B |
| Intangible Assets | $25.53M | $50.99M | $63.60M | $105.74M | $149.48M | $201.59M |
| Long-term Investments | $51.65M | $46.35M | - | - | - | - |
| Other Non-current Assets | $40.75M | $24.78M | $14.05M | $9.62M | $9.93M | $8.13M |
| Total Assets | $4.14B | $3.41B | $2.77B | $2.54B | $2.26B | $2.04B |
| Accounts Payable | $27.29M | $21.41M | $21.95M | $22.71M | $9.62M | $11.11M |
| Accrued Liabilities | $252.50M | $233.68M | $188.38M | $141.56M | $119.53M | $93.73M |
| Deferred Revenue | $1.09B | $987.95M | $811.06M | $688.55M | $509.27M | $384.06M |
| Total Current Liabilities | $1.38B | $1.26B | $1.04B | $865.60M | $647.91M | $488.90M |
| Long-term Debt | - | - | - | $273.92M | $391.91M | $509.99M |
| Deferred Tax Liabilities | $419.00K | $1.01M | $280.00K | $85.00K | $1.01M | - |
| Total Liabilities | $1.52B | $1.39B | $1.16B | $1.24B | $1.14B | $1.08B |
| Retained Earnings | $284.93M | $-198.76M | $-353.39M | $-461.35M | $-513.80M | $-594.03M |
| Total Stockholders Equity | $2.62B | $2.02B | $1.60B | $1.30B | $1.11B | $961.50M |
| Total Liabilities & Equity | $4.14B | $3.41B | $2.77B | $2.54B | $2.26B | $2.04B |
| Breakdown | TTM (Sep 30, 2025) |
FY 2024 (Mar 31, 2025) |
FY 2023 (Mar 31, 2024) |
FY 2022 (Mar 31, 2023) |
FY 2021 (Mar 31, 2022) |
FY 2020 (Mar 31, 2021) |
FY 2019 (Mar 31, 2020) |
|---|---|---|---|---|---|---|---|
| Net Income | - | $483.68M | $154.63M | $107.96M | $52.45M | $75.71M | $-418.02M |
| Stock-based Compensation | - | $271.70M | $208.90M | $146.87M | $99.54M | $57.78M | $222.48M |
| Change in Receivables | - | $24.03M | $161.89M | $94.91M | $108.85M | $81.99M | $44.02M |
| Operating Cash Flow | - | $459.42M | $378.11M | $354.88M | $250.92M | $220.44M | $-142.46M |
| Capital Expenditure | - | $26.11M | $26.46M | $21.54M | $17.70M | $14.08M | $19.72M |
| Acquisitions | - | $100.00K | $57.11M | - | $13.20M | - | - |
| Purchases of Investments | - | $145.56M | $104.21M | - | - | - | - |
| Investing Cash Flow | - | $-69.31M | $-193.05M | $-21.54M | $-30.89M | $-13.88M | $-20.61M |
| Debt Repayment | - | - | - | $281.12M | $120.00M | $120.00M | $515.19M |
| Stock Repurchased | - | $172.62M | - | - | $66.00K | $49.00K | $156.00K |
| Financing Cash Flow | - | $-151.63M | $50.66M | $-232.34M | $-80.66M | $-97.80M | $329.39M |
| Net Change in Cash | - | $238.06M | $223.63M | $92.38M | $138.00M | $111.79M | $161.86M |
SEC Filing Format - Data shown as it appears in the Q2 2026 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $493.85M | $418.13M | $971.20M | $817.35M |
| Cost of Revenue | $89.76M | $77.78M | $174.97M | $152.54M |
| Gross Profit | $404.08M | $340.35M | $796.23M | $664.81M |
| Operating Expenses | $331.12M | $293.32M | $660.92M | $575.76M |
| Research & Development | $114.99M | $95.37M | $223.16M | $182.94M |
| Operating Income | $72.97M | $47.03M | $135.31M | $89.06M |
| Interest Expense | - | - | $363.00K | $365.00K |
| Other Income/Expense | $894.00K | $-2.04M | $7.65M | $-4.07M |
| Income Before Tax | $87.11M | $57.84M | $168.50M | $110.61M |
| Income Tax Expense | $29.86M | $13.83M | $63.30M | $27.98M |
| Net Income | $57.24M | $44.01M | $105.20M | $82.63M |
| Basic EPS | 0.19 | 0.15 | 0.35 | 0.28 |
| Diluted EPS | 0.19 | 0.15 | 0.35 | 0.27 |
| Basic Shares Outstanding | $301.56M | $298.09M | $300.86M | $297.74M |
| Diluted Shares Outstanding | $304.30M | $301.37M | $304.80M | $301.71M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Mar 31, 2025 |
|---|---|---|
| Cash & Cash Equivalents | $1.23B | $1.02B |
| Short-term Investments | $89.64M | $96.19M |
| Accounts Receivable | $315.04M | $624.44M |
| Other Current Assets | $86.52M | $83.90M |
| Total Current Assets | $1.84B | $1.93B |
| Property Plant & Equipment | $66.08M | $61.52M |
| Goodwill | $1.34B | $1.34B |
| Intangible Assets | $24.05M | $25.53M |
| Long-term Investments | $54.54M | $51.65M |
| Other Non-current Assets | $41.32M | $40.75M |
| Total Assets | $4.08B | $4.14B |
| Accounts Payable | $21.62M | $27.29M |
| Accrued Liabilities | $230.03M | $252.50M |
| Deferred Revenue | $889.96M | $1.09B |
| Total Current Liabilities | $1.16B | $1.38B |
| Deferred Tax Liabilities | $871.00K | $419.00K |
| Total Liabilities | $1.30B | $1.52B |
| Retained Earnings | $390.12M | $284.93M |
| Total Stockholders Equity | $2.78B | $2.62B |
| Total Liabilities & Equity | $4.08B | $4.14B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $57.24M | $44.01M | $105.20M | $82.63M |
| Stock-based Compensation | - | - | $148.71M | $129.36M |
| Change in Receivables | - | - | $-320.55M | $-300.08M |
| Operating Cash Flow | - | - | $301.71M | $254.39M |
| Capital Expenditure | - | - | $11.67M | $6.87M |
| Acquisitions | - | - | - | $100.00K |
| Purchases of Investments | - | - | $63.76M | $80.02M |
| Investing Cash Flow | - | - | $-6.50M | $-46.62M |
| Stock Repurchased | - | - | $95.03M | $90.11M |
| Financing Cash Flow | - | - | $-99.08M | $-84.57M |
| Net Change in Cash | - | - | $207.98M | $128.19M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.